Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 242-245

  Braga, Raphael J ^a,b,d   Burdick, Katherine E ^d,e   DeRosse, Pamela ^a,d   Malhotra, Anil K ^a,b,c,d  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b Hofstra North Shore LIJ University   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Cannabis; Neurocognition; Prognosis

Indexed keywords

ADULT; ARTICLE; ATTENTION; BIPOLAR I DISORDER; CANNABIS ADDICTION; CLINICAL ASSESSMENT; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL PERFORMANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; RETROSPECTIVE STUDY; WORKING MEMORY;

ADULT; ATTENTION; BIPOLAR DISORDER; COGNITION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84872402942     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.05.025     Document Type: Article

References (20)

1. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 2004, 184:110-117.
2. Conway K.P., Compton W., Stinson F.S., Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2006, 67:247-257.
3. Dalton E.J., Cate-Carter T.D., Mundo E., Parikh S.V., Kennedy J.L. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disorders 2003, 5:58-61.
4. DeRosse P., Kaplan A., Burdick K.E., Lencz T., Malhotra A.K. Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophrenia Research 2010, 120:95-100.
5. Goldberg J.F., Garno J.L., Leon A.C., Kocsis J.H., Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. Journal of Clinical Psychiatry 1999, 60:733-740.
6. Hollingshead A.A. Four-Factor Index of Social Status 1975, Yale University, New Haven, CT.
7. Keefe R.S., Eesley C.E., Poe M.P. Defining a cognitive function decrement in schizophrenia. Biological Psychiatry 2005, 57:688-691.
8. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 2010, 36:1115-1130.
9. Lehman W.E., Simpson D.D. Employee substance use and on-the-job behaviors. Journal of Applied Psychology 1992, 77:309-321.
10. Lynskey M., Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000, 95:1621-1630.
11. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
12. Pope H.G., Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. Journal of American Medical Association 1996, 275:521-527.
13. Rabin R.A., Zakzanis K.K., George T.P. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophrenia Research 2011.
14. Ringen P.A., Vaskinn A., Sundet K., Engh J.A., Jonsdottir H., Simonsen C., Friis S., Opjordsmoen S., Melle I., Andreassen O.A. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychological Medicine 2010, 40:1337-1347.
15. Schweinsburg A.D., Brown S.A., Tapert S.F. The influence of marijuana use on neurocognitive functioning in adolescents. Current Drug Abuse Review 2008, 1:99-111.
16. Stinson F.S., Ruan W.J., Pickering R., Grant B.F. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychological Medicine 2006, 33:1447-1460.
17. Strakowski S.M., DelBello M.P., Fleck D.E., Adler C.M., Anthenelli R.M., Keck P.E., Arnold L.M., Amicone J. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Archives of General Psychiatry 2007, 64:57-64.
18. van Rossum I., Boomsma M., Tenback D., Reed C., van Os J. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. Journal of Nervous and Mental Disease 2009, 197:35-40.
19. Weiss R.D., Ostacher M.J., Otto M.W., Calabrese J.R., Fossey M., Wisniewski S.R., Bowden C.L., Nierenberg A.A., Pollack M.H., Salloum I.M., Simon N.M., Thase M.E., Sachs G.S. Does recovery from substance use disorder matter in patients with bipolar disorder?. Journal of Clinical Psychiatry 2005, 66:730-735.
20. Yucel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., Conus P., Takagi M.J., Fornito A., Wood S.J., McGorry P.D., Pantelis C. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 2010, 38:316-330.